IOVANCE BIOTHERAPEUTICS, INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | — | $656.5M | $67.3M |
| FY2021 | — | $621.7M | $78.2M |
| FY2022 | — | $499.6M | $231.7M |
| FY2023 | — | $584.6M | $114.9M |
| FY2024 | — | $710.4M | $115.7M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | — | $656.5M | $67.3M |
| FY2021 | — | $621.7M | $78.2M |
| FY2022 | — | $499.6M | $231.7M |
| FY2023 | — | $584.6M | $114.9M |
| FY2024 | — | $710.4M | $115.7M |